HRT FINANCIAL LP - CHINA PHARMA HLDGS INC ownership

CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 8 filers reported holding CHINA PHARMA HLDGS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of CHINA PHARMA HLDGS INC
ValueSharesWeighting
Q1 2022$6,000
-80.0%
17,236
-72.6%
0.00%
Q4 2021$30,000
-81.0%
62,911
-77.8%
0.00%
-100.0%
Q3 2021$158,000
-16.0%
282,945
+8.4%
0.00%
-50.0%
Q2 2021$188,000
-16.4%
260,918
-2.7%
0.00%0.0%
Q1 2021$225,000
+2712.5%
268,129
+1366.5%
0.00%
Q4 2020$8,000
-85.2%
18,284
-87.8%
0.00%
-100.0%
Q3 2020$54,000
+38.5%
150,355
+152.9%
0.00%
+100.0%
Q2 2020$39,00059,4610.00%
Other shareholders
CHINA PHARMA HLDGS INC shareholders Q3 2021
NameSharesValueWeighting ↓
POPE ASSET MANAGEMENT, LLC 2,104,826$632,0000.51%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 1,290,463$387,0000.07%
GLENHILL ADVISORS LLC 200,000$60,0000.01%
Renaissance Technologies 136,300$41,0000.00%
Virtu KCG Holdings LLC 19,910$6,0000.00%
UBS Group AG 5,618$2,0000.00%
View complete list of CHINA PHARMA HLDGS INC shareholders